Author

Shinji Harada

Observed names: Harada Shinji, S Harada, S. Harada, SHINJI HARADA, Shinji HARADA, Shinji Harada .

Observed institutions: Tokyo Medical and Dental University, Centers for Disease Control and Prevention, Nebraska Medical Center, Mansoura University, Yamaguchi University, Kyoto University, Karolinska Institutet, University of Nebraska Medical Center, UConn Health, University of California, Davis, Kumamoto University

ORCID: 0000-0001-5348-406X

Observed ORCID: 0000-0001-5348-406X

OpenAlex ID: A5103267440

Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay

1985 · Shinji Harada, Yoshio Koyanagi, et al. · Science · 857

Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells

1991 · Mari Kannagi, Shinji Harada, et al. · International Immunology · 254

Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4

1986 · R Kikukawa, Y Koyanagi, et al. · Journal of Virology · 220

PDF

The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope

2005 · Shinji Harada · Biochemical Journal · 134

Tumor promoter, TPA, enhances replication of HTLV-III/LAV

1986 · Shinji Harada, Yoshio Koyanagi, et al. · Virology · 131

Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro

1986 · H Nakashima, T Matsui, et al. · Antimicrobial Agents and Chemotherapy · 127

Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor

1994 · M A el-Farrash, M J Kuroda, et al. · Journal of Virology · 94

Infection of human T-lymphotropic virus type-1 (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): Chronological studies of early events

1985 · Shinji Harada, Yoshio Koyanagi, et al. · Virology · 90

Specific and Independent Recognition of U3 and U5 att Sites by Human Immunodeficiency Virus Type 1 Integrase In Vivo

1998 · Takao Masuda, Marcelo J. Kuroda, et al. · Journal of Virology · 83

Involvement of both the V2 and V3 Regions of the CCR5-Tropic Human Immunodeficiency Virus Type 1 Envelope in Reduced Sensitivity to Macrophage Inflammatory Protein 1α

2000 · Yosuke Maeda, Mohamed Foda, et al. · Journal of Virology · 77

Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro

1990 · M Kannagi, T Masuda, et al. · Journal of Virology · 72

Cell‐mediated immunity to Epstein‐Barr virus (EBV) and natural killer (NK)‐cell activity in the X‐linked lymphoproliferative syndrome

1982 · Shinji Harada, Thomas Bechtold, et al. · International Journal of Cancer · 69

Expression of the target antigen for cytotoxic T lymphocytes on adult T‐cell‐leukemia cells

1993 · Mari Kannagi, Shuzo Matsushita, et al. · International Journal of Cancer · 55

Establishment of a high production system for AIDS retroviruses with a human T-leukemic cell line Molt-4

1986 · Yoshio Koyanagi, Shinji Harada, et al. · Cancer Letters · 54

Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region.

1990 · T Masuda, S Matsushita, et al. · The Journal of Immunology · 52

Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV)

1986 · Shinji Harada, David T. Purtilo, et al. · Journal of Immunological Methods · 50

Effect of heat and fresh human serum on the infectivity of human T-cell lymphotropic virus type III evaluated with new bioassay systems

1985 · S Harada, H Yoshiyama, et al. · Journal of Clinical Microbiology · 48

PDF

The antiretroviral potency of APOBEC1 deaminase from small animal species

2008 · Terumasa Ikeda, Takeo Ohsugi, et al. · Nucleic Acids Research · 47

PDF

Interleukin-8 is constitutively and commonly produced by various human carcinoma cell lines

1992 · Kiyoshi Sakamoto, Takao Masuda, et al. · International Journal of Clinical & Laboratory Research · 37

Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 Loop Library

2005 · Keisuke Yusa, Yosuke Maeda, et al. · Journal of Biological Chemistry · 35

PDF

Prostaglandin E2, a seminal constituent, facilitates the replication of acquired immune deficiency syndrome virus in vitro.

1986 · S Kuno, R Ueno, et al. · Proceedings of the National Academy of Sciences · 35

Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.

1994 · M Kannagi, S Matsushita, et al. · PubMed · 34

Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line

1988 · T. Goto, S. Harada, et al. · Archives of Virology · 34

Recombinant human interferon gamma suppresses HTLV‐III replication in vitro

1986 · Hideki Nakashima, Tsutomu Yoshida, et al. · International Journal of Cancer · 32

Influence of membrane fluidity on human immunodeficiency virus type 1 entry

2005 · Shinji Harada, Keisuke Yusa, et al. · Biochemical and Biophysical Research Communications · 31

Works count: 118

Citation count: 3,510

H-index: 28

I10-index: 61